Unknown

Dataset Information

0

In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii.


ABSTRACT: The antigen-specific primary activation of CD4+ T cells was studied in vivo by adoptive transfer of ovalbumin-specific transgenic T cells (KJ1-26+ CD4+) following intranasal immunization with recombinant Streptococcus gordonii. A strain of S. gordonii expressing on its surface a model vaccine antigen fused to the ovalbumin (OVA) peptide from position 323 to 339 was constructed and used to study the OVA-specific T-cell activation in nasal mucosa-associated lymphoid tissue (NALT), lymph nodes, and spleens of mice immunized by the intranasal route. The recombinant strain, but not the wild type, activated the OVA-specific CD4+ T-cell population in the NALT (89% of KJ1-26+ CD4+ T cells) just 3 days following immunization. In the cervical lymph nodes and in the spleen, the percentage of proliferating cells was initially low, but it reached the peak of activation at day 5 (90%). This antigen-specific clonal expansion of KJ1-26+ CD4+ T cells after intranasal immunization was obtained with live and inactivated recombinant bacteria, and it indicates that the NALT is the site of antigen-specific T-cell priming.

SUBMITTER: Medaglini D 

PROVIDER: S-EPMC1459748 | biostudies-literature | 2006 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii.

Medaglini Donata D   Ciabattini Annalisa A   Cuppone Anna Maria AM   Costa Caterina C   Ricci Susanna S   Ricci Susanna S   Costalonga Massimo M   Pozzi Gianni G  

Infection and immunity 20060501 5


The antigen-specific primary activation of CD4+ T cells was studied in vivo by adoptive transfer of ovalbumin-specific transgenic T cells (KJ1-26+ CD4+) following intranasal immunization with recombinant Streptococcus gordonii. A strain of S. gordonii expressing on its surface a model vaccine antigen fused to the ovalbumin (OVA) peptide from position 323 to 339 was constructed and used to study the OVA-specific T-cell activation in nasal mucosa-associated lymphoid tissue (NALT), lymph nodes, and  ...[more]

Similar Datasets

| S-EPMC5207509 | biostudies-literature
| S-EPMC6414371 | biostudies-literature
| S-EPMC3327732 | biostudies-literature
| S-EPMC3647999 | biostudies-literature
| S-EPMC5958783 | biostudies-literature
| S-EPMC2746692 | biostudies-literature
| S-EPMC7755246 | biostudies-literature
| S-EPMC8552878 | biostudies-literature
| S-EPMC5797862 | biostudies-literature
| S-EPMC6443155 | biostudies-literature